Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Endocyte (NASDAQ:ECYT)’s shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings, American Banking and Market News reports. 13,778,961 shares changed hands during trading, an increase of 624% from the previous session’s volume of 1,903,723 shares. Endocyte, Inc. (NASDAQ:ECYT) stock performance was 61.91% in last session and finished the day at $ 6.62. Traded volume was 17,639,435 shares in … Continue reading Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Adam Keintzel05/0505/05

Featured, Financial, Stock Movers

T-Mobile US Inc (NYSE:TMUS) Shares Jump Pre-Market

T-Mobile US Inc(NYSE:TMUS) shares rose in Thursday’s pre-market session despite a bigger-than-expected Q1 loss and a cut to the wireless-telecommunications company’s forecast for 2014 adjusted earnings before interest, taxes, depreciation and amortization, as investors were encouraged by strong net additions in the quarter and a boost to its 2014 additions guidance. TMUS was up 8% at $31.64 in recent pre-market trading, nearing its 52-week high … Continue reading T-Mobile US Inc (NYSE:TMUS) Shares Jump Pre-Market

Colin Pettis05/01

Consumer Goods, Featured

Nordstrom, Inc. Earnings Preview

We expect Nordstrom to report a relatively in-line quarter compared with the Street consensus of $1.34 as well as implied guidance of $1.30-$1.35. Overall, we project 1% total sales growth, to $3.7 billion. We project gross margin, including the impact of Fashion Rewards, to decline 35 basis points, and SG&A deleverage of 40 basis points given the softer top line and continued investment. Nordstrom is … Continue reading Nordstrom, Inc. Earnings Preview

John Meady02/1402/14

Featured, Services Sector, Tech IPO

Realty Income Posts Rapid Increase in Acquisition Numbers

Realty Income announced $503 million of acquisitions for its third quarter as well as the issuance of as many as 7.475 million shares of its common stock to help fund the deals. This acquisition activity brings Realty Income to a total of $4.57 billion of new property investments so far in 2013, its most acquisitive year ever. Of that $4.57 billion total, $3.2 billion was spent … Continue reading Realty Income Posts Rapid Increase in Acquisition Numbers

Adam Keintzel12/3101/07Leave a comment

Diversified Tech, Featured, Finance

Forward Air Posts Strong Revenue in Q3

Forward Air’s third-quarter consolidated revenue increased 18.5%. Excluding the addition of its new temperature-controlled operation, TQI, which was acquired in March, revenue was up 10%. The core airport-to-airport business grew 4% from last year, driven by solid 5.5% tonnage growth, partly offset by a 1% fall in total yield. Forward Air Solutions (the pooled distribution business) posted solid 55% sales growth, reflecting previously announced new … Continue reading Forward Air Posts Strong Revenue in Q3

Chris Lewis12/3001/07Leave a comment

Diversified Tech, Featured, Finance, Services Sector

Weak Hospital Spending Hurts Varian Medical Systems Q4 Results

Varian Medical Systems reported fairly weak fiscal fourth-quarter results. The company’s performance continues to be affected by tightening U.S. radiology reimbursement for freestanding clinics and the generally weak hospital spending environment. Our narrow moat and positive moat trend ratings remain intact; we continue to believe Varian is well positioned to capitalize on its strong technological platform and produce strong results over the next decade. We’re … Continue reading Weak Hospital Spending Hurts Varian Medical Systems Q4 Results